טוען...
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program
AIMS/HYPOTHESIS: The primary analysis of the Canagliflozin cardioVascular Assessment Study (CANVAS) Program showed canagliflozin to have a beneficial effect on cardiovascular and renal outcomes in people with type 2 diabetes at high cardiovascular risk, but also an unexpected increased risk of major...
שמור ב:
| הוצא לאור ב: | Diabetologia |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Berlin Heidelberg
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6509073/ https://ncbi.nlm.nih.gov/pubmed/30868176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-019-4839-8 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|